Elocon and Mobic drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Elocon (mometasone furoate) and Mobic (meloxicam). Common drug interactions include blood sodium increased among females and abdominal discomfort among males.

The phase IV clinical study analyzes what interactions people have when they take Elocon and Mobic. It is created by eHealthMe based on reports of 29 people who take the same drugs from the FDA, and is updated regularly.

What is Elocon?

Elocon has active ingredients of mometasone furoate. It is often used in eczema. eHealthMe is studying from 2,019 Elocon users. Check the latest studies of Elocon.

What is Mobic?

Mobic has active ingredients of meloxicam. It is often used in arthritis. eHealthMe is studying from 26,684 Mobic users. Check the latest studies of Mobic.

On Jul, 11, 2026

29 people who take Elocon and Mobic together, and have interactions are studied.

What are the common drug interactions of Elocon and Mobic, by gender? *:

female:

Blood sodium increased
Chronic kidney disease
Fall
Infusion related reaction
Headache (pain in head)
High density lipoprotein decreased
Benign neoplasm of skin (benign (non-cancerous) tumours of the skin)
Blood glucose increased
Colitis ulcerative (inflammation of colon with ulcer)
Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)

male:

Abdominal discomfort
Anger
Depression
Diarrhoea
Haemorrhage (bleeding)
Increased appetite
International normalised ratio increased
Malaise (a feeling of general discomfort or uneasiness)
Nightmare (unpleasant dream)

What are the common drug interactions of Elocon and Mobic, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Abdominal discomfort
Diarrhoea
Increased appetite
Malaise (a feeling of general discomfort or uneasiness)

30-39:

n/a

40-49:

High density lipoprotein decreased
Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
Headache (pain in head)
Limb discomfort (discomfort in leg)
Migraine (headache)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Therapeutic response unexpected
Weight decreased

50-59:

Haemorrhage (bleeding)
International normalised ratio increased
Nausea (feeling of having an urge to vomit)

60+:

Chronic kidney disease
Benign neoplasm of skin (benign (non-cancerous) tumours of the skin)
Abdominal pain upper
Back pain
Bone pain
Chills (felling of cold)
Fatigue (feeling of tiredness)
Feeling cold
Gait disturbance
Headache (pain in head)

What are the existing conditions these people have? *

Pain: 13 people, 44.83%
High Blood Pressure: 9 people, 31.03%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 20.69%
Depression: 6 people, 20.69%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 17.24%
Cough: 5 people, 17.24%
Psoriasis (immune-mediated disease that affects the skin): 5 people, 17.24%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 17.24%
Infection: 4 people, 13.79%
Asthma: 4 people, 13.79%

* Approximation only. Some reports may have incomplete information.

Do you take Elocon and Mobic?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously